Cancer · 1990 · 26 citations · 16 references
MedicineOncologyPathologyHepatologyNeoplasiaTumor PathologyHepatic PathologyHepatocellular CarcinomaLiver CancerTumor AntigensTumor MarkersTumor-associated AntigensAlpha-fetoprotein BiomarkerCirculating Tumor MarkersHepatic BiomarkersHepatic TumorsHepatitis B E AntigenSerum Tumor Markers
One hundred thirty-five hepatocellular carcinomas were examined for the presence of antigenic tumor markers by the avidin-biotin-peroxidase complex method. Ninety-seven were from the US and 38 came from Argentina. The following markers were tested: alpha-fetoprotein (AFP), alpha-1-antitrypsin (AAT), hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg), hepatitis D delta antigen (HD delta Ag), and Mallory's bodies (MB). In the US cases, AFP was present in 43%, AAT in 41%, HBsAg in 17%, and MB in 48%. Both HBcAg and HD delta Ag were absent. In the cases from Argentina, AFP was found in 26% and AAT in 18%. None of the other antigens were seen. Thirteen US tumors expressed three antigens and two four antigens simultaneously. This study reveals in humans a heterogenous expression of antigens by neoplastic hepatocytes with geographic differences, possibly due to multiple factors such as alcohol consumption or prevalence of hepatitis B infection.
16
[Pathology of hepatocellular carcinoma].
PubMed · 1983 · 314 citations
Advances in immunohistochemistry
Walter H. C. Burgdorf · Journal of the American Academy of Dermatology · 1984 · 280 citations
Distribution of five antigens in hepatocellular carcinoma.
Thung Sn, Gerber Ma, Euzenir Nunes Sarno et al. · PubMed · 1979 · 131 citations
Medicine, Immunology, Oncology +12
Masao Omata, Mary Ashcavai, Choong-Tsek Liew et al. · PubMed · 1979 · 118 citations